Header Logo

Payal Gurnani

Concepts (46)

Back to Profile
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.


Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Pharmacists
2
2021
17
0.870
 Why?
Marfan Syndrome
1
2018
4
0.590
 Why?
Drug-Eluting Stents
1
2018
17
0.580
 Why?
Extracorporeal Membrane Oxygenation
1
2018
23
0.570
 Why?
Fluid Therapy
1
2010
26
0.330
 Why?
Shock, Septic
1
2010
59
0.330
 Why?
Practice Guidelines as Topic
1
2010
261
0.300
 Why?
Anti-Bacterial Agents
1
2010
380
0.270
 Why?
Professional Role
2
2021
31
0.210
 Why?
Epoprostenol
1
2021
6
0.180
 Why?
Pulmonary Ventilation
1
2021
10
0.180
 Why?
Nebulizers and Vaporizers
1
2021
21
0.180
 Why?
Antihypertensive Agents
1
2021
54
0.180
 Why?
Hypercalcemia
1
2020
7
0.170
 Why?
Calcitonin
1
2020
14
0.170
 Why?
Diphosphonates
1
2020
16
0.170
 Why?
Intubation, Intratracheal
1
2021
96
0.170
 Why?
Critical Care
1
2021
122
0.160
 Why?
Patient Care Team
1
2021
119
0.160
 Why?
Pandemics
1
2021
243
0.160
 Why?
Neoplasms
1
2020
242
0.140
 Why?
Intensive Care Units
1
2019
265
0.130
 Why?
Emergency Service, Hospital
1
2019
270
0.120
 Why?
Humans
6
2021
27307
0.120
 Why?
Adult
3
2021
7945
0.110
 Why?
Male
4
2021
14887
0.100
 Why?
Resuscitation
1
2010
11
0.080
 Why?
Clinical Protocols
1
2010
58
0.080
 Why?
Hospital Mortality
1
2010
141
0.080
 Why?
Evidence-Based Medicine
1
2010
164
0.080
 Why?
Multivariate Analysis
1
2010
331
0.080
 Why?
Middle Aged
3
2021
9068
0.070
 Why?
Aged
3
2021
9120
0.070
 Why?
Cross Infection
1
2010
309
0.070
 Why?
Time Factors
1
2010
1444
0.060
 Why?
Prospective Studies
1
2010
1792
0.060
 Why?
Female
3
2021
15334
0.050
 Why?
Reagent Kits, Diagnostic
1
2021
6
0.050
 Why?
Retrospective Studies
2
2021
3551
0.050
 Why?
Administration, Inhalation
1
2021
37
0.050
 Why?
Treatment Outcome
1
2010
3540
0.040
 Why?
Dose-Response Relationship, Drug
1
2021
331
0.040
 Why?
Case-Control Studies
1
2021
589
0.040
 Why?
Pharmacy Service, Hospital
1
2019
12
0.040
 Why?
Cost Savings
1
2019
32
0.040
 Why?
Critical Illness
1
2019
120
0.040
 Why?
Gurnani's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (46)
Explore
_
Co-Authors (6)
Explore
_
Similar People (60)
Explore
_
Same Department Expand Description
Explore
_